{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:27:59Z","timestamp":1781328479107,"version":"3.54.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014470","name":"Netherlands Heart Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Pathogenic variants in <jats:italic>phospholamban<\/jats:italic> (<jats:italic>PLN<\/jats:italic>, like p. Arg14del), are found in patients diagnosed with arrhythmogenic (ACM) and dilated cardiomyopathy (DCM). Fibrosis formation in the heart is one of the hallmarks in <jats:italic>PLN<\/jats:italic> p.Arg14del carriers. During collagen synthesis and breakdown, propeptides are released into the circulation, such as procollagen type I carboxy-terminal propeptide (PICP) and C-terminal telopeptide collagen type I (ICTP).<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> To investigate if PICP\/ICTP levels in blood are correlative biomarkers for clinical disease severity and outcome in <jats:italic>PLN<\/jats:italic> p.Arg14del variant carriers.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Serum and EDTA blood samples were collected from 72 <jats:italic>PLN<\/jats:italic> p.Arg14del carriers (age 50.5 years, 63% female) diagnosed with ACM (<jats:italic>n<\/jats:italic> = 12), DCM (<jats:italic>n<\/jats:italic> = 14), and preclinical variant carriers (<jats:italic>n<\/jats:italic> = 46). PICP levels were measured with an enzyme-linked immune sorbent assay and ICTP with a radio immuno-assay. Increased PICP\/ICTP ratios suggest a higher collagen deposition. Clinical data including electrocardiographic, and imaging results were adjudicated from medical records.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> No correlation between PICP\/ICTP ratios and late gadolinium enhancement (LGE) was found. Moderate correlations were found between the PICP\/ICTP ratio and end-diastolic\/systolic volume (both <jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub> = 0.40, <jats:italic>n<\/jats:italic> = 23, <jats:italic>p<\/jats:italic> = 0.06). PICP\/ICTP ratio was significantly higher in patients with T wave inversion (TWI), especially in leads V4\u2013V6, II, III, and aVF (<jats:italic>p<\/jats:italic> &amp;lt; 0.022) and in patients with premature ventricular contractions (PVCs) during an exercise tolerance test (<jats:italic>p<\/jats:italic> = 0.007).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> High PICP\/ICTP ratios correlated with clinical parameters, such as TWI and PVCs. Given the limited size and heterogeneity of the patient group, additional studies are required to substantiate the incremental prognostic value of these fibrosis biomarkers in <jats:italic>PLN<\/jats:italic> p.Arg14del patients.<\/jats:p>","DOI":"10.3389\/fcvm.2021.802998","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T04:56:18Z","timestamp":1642049778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the Correlation Between Fibrosis Biomarkers and Clinical Disease Severity in PLN p.Arg14del Patients"],"prefix":"10.3389","volume":"8","author":[{"given":"Stephanie M.","family":"van der Voorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimount","family":"Bourfiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneline S. J. M.","family":"te Riele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"de Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom E.","family":"Verstraelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Ann","family":"Remme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon A. B.","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16710","DOI":"10.1038\/s41598-020-70780-x","article-title":"The phospholamban p(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy","volume":"10","author":"Eijgenraam","year":"2020","journal-title":"Sci Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/ehjci\/jey047","article-title":"Myocardial fibrosis as an early feature in phospholamban pArg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging","volume":"20","author":"Te Rijdt","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.hrthm.2009.01.016","article-title":"Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes","volume":"6","author":"Posch","year":"2009","journal-title":"Heart Rhythm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.hrthm.2017.03.034","article-title":"Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies","volume":"14","author":"Sepehrkhouy","year":"2017","journal-title":"Heart Rhythm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/FJC.0b013e318207a35f","article-title":"Fibrosis and cardiac arrhythmias","volume":"57","author":"de Jong","year":"2011","journal-title":"J Cardiovasc Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/FJC.0b013e31821823d9","article-title":"Biomarkers of myocardial fibrosis","volume":"57","author":"de Jong","year":"2011","journal-title":"J Cardiovasc Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12471-011-0226-x","article-title":"Monitoring cardiac fibrosis: a technical challenge","volume":"20","author":"de Jong","year":"2012","journal-title":"Neth Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0002-9149(99)80686-9","article-title":"Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis","volume":"75","author":"Klappacher","year":"1995","journal-title":"Am J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCHEARTFAILURE.108.828343","article-title":"Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study","volume":"2","author":"Barasch","year":"2009","journal-title":"Circ Heart Fail."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1161\/01.CIR.0000090687.97972.10","article-title":"Myocardial collagen turnover in hypertrophic cardiomyopathy","volume":"108","author":"Lombardi","year":"2003","journal-title":"Circulation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1161\/HYPERTENSIONAHA.109.149112","article-title":"Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction","volume":"55","author":"Gonzalez","year":"2010","journal-title":"Hypertension."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1161\/01.CIR.101.14.1729","article-title":"Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease","volume":"101","author":"Querejeta","year":"2000","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.109.912774","article-title":"Circulating biomarkers of collagen metabolism in cardiac diseases","volume":"121","author":"Lopez","year":"2010","journal-title":"Circulation."},{"key":"B19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/europace\/euv340","article-title":"Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis","volume":"18","author":"Haugaa","year":"2016","journal-title":"Europace."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/01.CIR.62.5.1054","article-title":"Echocardiographic measurements in normal subjects from infancy to old age","volume":"62","author":"Henry","year":"1980","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12471-019-1270-1","article-title":"The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update","volume":"27","author":"Bosman","year":"2019","journal-title":"Neth Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban pArg14del mutation carriers-reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1136\/heartjnl-2019-316105","article-title":"Electrocardiographic associations with myocardial fibrosis among sudden cardiac death victims","volume":"106","author":"Holmstrom","year":"2020","journal-title":"Heart."},{"key":"B24","doi-asserted-by":"publisher","first-page":"50053","DOI":"10.3390\/jcm6050053","article-title":"The soft- and hard-heartedness of cardiac fibroblasts: mechanotransduction signaling pathways in fibrosis of the heart","volume":"6","author":"Herum","year":"2017","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCEP.111.963348","article-title":"Premature ventricular contraction-induced cardiomyopathy: a treatable condition","volume":"5","author":"Lee","year":"2012","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1148\/radiol.2402051038","article-title":"Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study","volume":"240","author":"Knaapen","year":"2006","journal-title":"Radiology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1161\/JAHA.117.007124","article-title":"Biomarkers of myocardial fibrosis: revealing the natural history of fibrogenesis in fabry disease cardiomyopathy","volume":"7","author":"Aguiar","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1253\/circj.71.929","article-title":"Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function","volume":"71","author":"Kitahara","year":"2007","journal-title":"Circ J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.802998\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T04:56:20Z","timestamp":1642049780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.802998\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":29,"alternative-id":["10.3389\/fcvm.2021.802998"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.802998","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"article-number":"802998"}}